Key result
A literature review evaluated the significance, effectiveness, and side effects of beta-adrenolytic drugs in the pharmacotherapy of anxiety disorders.
Why the study?
Do beta blockers improve symptoms in patients with anxiety disorders?
Do beta blockers improve symptoms in patients with anxiety disorders?
This review examines the anxiolytic potential and side effects of beta blockers in the treatment of anxiety disorders.
Beta blockers lack definitive support for anxiety; leaves open need for RCTs on efficacy and safety.
SummaryIntroduction: Beta blockers are mainly used in treating cardiovascular diseases. However, it has been observed that these drugs have also an anxiolytic potential. Over the years, a number of clinical trials have been conducted aimed at determining the effectiveness of beta blockers in treating anxiety disorders.The aim of the article: The main objective of the article is to present the significance and position of adrenolytic drugs in the pharmacotherapy of anxiety disorders on the basis of available literature. Moreover, the authors also decided to take into account the data from current research results, considering the problem of side effects of using adrenolytic drugs - especially the controversial reports on their effect on the development of affective disorders.Method: An analysis was conducted of articles from Medline/PubMed database, selected on the basis of the following key words: anxiety disorders, beta blockers, adrenolytic drugs, as well as on the basis of their dates of publication: 1960-2017. In order to conduct a reliable and complete review of literature, the authors decided to include works from quite an extended period of time. The articles included in the review were published in Polish and English.
No takes yet. Share an insight, caveat, or question.
Brudkowska et al. (2018) conducted a review in Anxiety disorders. Beta blockers (adrenolytic drugs) was evaluated. A literature review evaluated the significance, effectiveness, and side effects of beta-adrenolytic drugs in the pharmacotherapy of anxiety disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: